In the present study, we investigated the activation of the NF-κB transcription factor in breast cancer in terms of ER signalling and the hyperactivation of MAPK due to EGFR and/or ErbB2 overexpression, with special emphasis on the IBC phenotype. The gene discussed is EGFR; the disease is breast cancer.